CAPR Suppliers & Customers — Capricor Therapeutics, Inc. Supply Chain from SEC Filings | Varamir

Sign in · build your desk

Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.

Sources

sec edgar · verbatim disclosure

Show the filing sentences· 11

Each tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.

—Cedars-Sinai Medical Centerbuys from
“On January 4, 2010, Capricor entered into an Exclusive License Agreement with CSMC (the "Original CSMC License Agreement"), for certain intellectual property related to its CDC technology.”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—Johns Hopkins Universitybuys from
“Capricor and JHU entered into an Exclusive License Agreement, effective June 22, 2006 (the "JHU License Agreement"), which provides for the grant of an exclusive, world-wide, royalty-bearing license by JHU to Capricor (with the right to sublicense) to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how.”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—Life Technologies Corporationbuys from
“On March 7, 2022, Capricor entered into a non-exclusive cell line license agreement with Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, Inc., for the supply of certain cells which we are utilizing in connection with the development of our exosomes platform.”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—Nippon Shinyaku Co., Ltd.sells to
“We will depend on our exclusive distributor, Nippon Shinyaku, for the commercial sale of Deramiocel in Duchenne muscular dystrophy ("DMD") in the United States and Japan, if regulatory approval is obtained in those territories.”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—Università Degli Studi Di Roma La Sapienzabuys from
“Capricor has entered into exclusive license agreements for intellectual property rights related to certain cardiac-derived cells with Università Degli Studi Di Roma La Sapienza (the "University of Rome"), Johns Hopkins University and Cedars-Sinai Medical Center.”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—National Institute of Allergy and Infectious Diseasessells to
“As part of Project NextGen, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is conducting a Phase 1 clinical study with our StealthX™ vaccine which is currently ongoing.”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—Cedars-Sinai Medical Centersells to
“Our collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—Department of Defensesells to
“Our collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—Johns Hopkins Universitysells to
“Our collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—National Institutes of Healthsells to
“Our collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869
—U.S. Army Institute of Surgical Researchsells to
“Our collaborations and research around exosomes include the National Institutes of Health ("NIH"), the National Institute of Allergy and Infectious Diseases ("NIAID"), Johns Hopkins University ("JHU"), the Department of Defense ("DoD"), the U.S. Army Institute of Surgical Research ("USAISR"), and Cedars-Sinai Medical Center ("CSMC").”
FILING10-K0001104659-26-029580filed 2026-03-17cik 0001133869

Watchlist prices, news filtered to it, and its next report on your desk.